Switch to
View more

Ajooni Biotech Ltd

AJOONI
Health CarePharmaceuticals
SmallcapWith a market cap of ₹42 cr, stock is ranked 2,635
High RiskStock is 3.10x as volatile as Nifty
43.100.75 (+1.77%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹42 cr, stock is ranked 2,635
High RiskStock is 3.10x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
39.98
PB RatioPB Ratio
2.71
Dividend YieldDiv. Yield
Sector PESector PE
38.38
Sector PBSector PB
4.85
Sector Div YldSctr Div Yld
0.73%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ajooni Biotech Pvt Ltd is a manufacturer of medicinals and botanicals

Investor PresentationView older 

Jun 29, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

201920202021202240.0640.0951.0674.080.410.330.371.06
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Outcome of Board Meeting 
Announced OnAug 5, 2022

Ajooni Biotech Limited has informed the Exchange about Board Meeting held on 05-Aug-2022 to consider financial statements for the quarter period ended June 2022. | Download

Ajooni Biotech Limited has informed the Exchange about Board Meeting held on 05-Aug-2022 to consider financial statements for the quarter period ended June 2022. | Download

General updates 
Announced OnJul 14, 2022

Ajooni Biotech Limited has informed the Exchange about NEW MILESTONE ACHIEVED-INITIAL BREAKTHROUGH RECEIEVED FROM COOPERATIVE MILK SOCIETY FOR SUPPLY OF MINERAL MIXTURE | Download

Ajooni Biotech Limited has informed the Exchange about NEW MILESTONE ACHIEVED-INITIAL BREAKTHROUGH RECEIEVED FROM COOPERATIVE MILK SOCIETY FOR SUPPLY OF MINERAL MIXTURE | Download

General updates 
Announced OnJul 11, 2022

Ajooni Biotech Limited has informed the Exchange about Undertaking of functional website | Download

Ajooni Biotech Limited has informed the Exchange about Undertaking of functional website | Download

See all events